Previous 10 |
VanEck, one of the largest providers of exchange traded funds (“ETFs”) in the U.S. and worldwide with approximately $47.8 billion in assets under management as of January 31, 2019, announced today that it plans to close and liquidate three VanEck Vectors ETFs. On March 4, 2...
According to the Centers for Medicare & Medicaid Services (CMS), U.S. healthcare spending is expected to rise 5.5% each year over the next decade, reaching ~$6T by 2027 (19.4% of GDP). More news on: ProShares Ultra Nasdaq Biotechnology ETF, The Gabelli Healthcare & Wellness Rx Tr...
In a statement , FDA commissioner Scott Gottlieb, M.D. announces a new pathway for accelerated view of marketing applications from generic drugmakers for off-patent branded medicines facing no generic competition, a situation characterizing "hundreds" of such drugs that serve small patient ...
Non-profit Civica Rx, formed by a consortium of hospital groups, expects to be able to offer about 20 generic medicines this year aimed aimed at preventing shortages and sidestepping price hikes. Most have been on the market for many decades. It forecasts that its lineup will expand to ~10...
News, Short Squeeze, Breakout and More Instantly...
Market Vectors Generic Drugs ETF Company Name:
GNRX Stock Symbol:
NASDAQ Market:
VanEck, one of the largest providers of exchange traded funds (“ETFs”) in the U.S. and worldwide with approximately $47.8 billion in assets under management as of January 31, 2019, announced today that it plans to close and liquidate three VanEck Vectors ETFs. On March 4, 2...